Q2 2021 Entera Bio Ltd Earnings Call Transcript
Good morning, and welcome to Entera Bio's conference call to discuss the financial and operating results for the 6 months ended June 30, 2021. (Operator Instructions)
I would now like to hand the conference over to Ramesh Ratan, the U.S.-based CFO of Entera. Please go ahead.
Good morning, and welcome to the call. Joining me on today's call are Spiros Jamas, our CEO; Arthur Santora, our CMO; and Phillip Schwartz, our President of R&D. A press release announcing Entera's financial and operating results for the first 6 months ended June 30, 2021, was issued earlier today. For those of you who have not seen it, it's available on the Investors section of our website, www.enterabio.com. On our call this morning, we will share with you a business update and review of our financial results, which will be followed by a question-and-answer session.
Before we begin our prepared remarks, I would like to remind you that various statements we make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |